OpenLegislation

Division 5.1.1 Medical data

United Kingdom

Original text. Later amendments are not shown.

Where available, and without prejudice to the provisions of F1the EU-derived domestic legislation which transposed Article 10 of Directive 98/24/EC, practical data and information relevant to the recognition of the symptoms of infection or pathogenicity and on the effectiveness of first aid and therapeutic measures have to be submitted. Where relevant, the effectiveness of potential antagonists, shall be investigated and reported. Where relevant, methods to kill or render the micro-organism uninfective must be indicated (see point 3.8).

Data and information relevant to the effects of human exposure, where available and of the necessary quality, are of particular value, in confirming the validity of extrapolations made and conclusions reached with respect to target organs, virulence, and the reversibility of adverse effects. Such data can be generated following accidental or occupational exposure.

Annotations

Textual amendments

F1

Words in Annex Pt. B point 5.1.1 inserted (31.12.2020) by The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 (S.I. 2019/556), regs. 1(1), 21(5)(c)(iii); 2020 c. 1, Sch. 5 para. 1(1)